UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genes
Yasuyuki Sera(Tokyo Women's Medical University), Hiroaki Honda(Tokyo Women's Medical University), Kohei Kobatake(Hiroshima University), Akiko Nagamachi(Hiroshima University), Norimasa Yamasaki(Hiroshima University), Toshiya Inaba(Hiroshima University), Atsushi Iwama(Chiba University), Tatsuo Ichinohe(Hiroshima University), Keiyo Takubo(Keio University), Toshio Suda(Chinese Academy of Sciences), Kenichiro Ikeda(Hiroshima University), Miho Koizumi(Tokyo Women's Medical University), Yoshihiko Miyakawa(Tokyo Women's Medical University), Masayuki Iwasaki(Tokyo Women's Medical University), Akinori Kanai(Frontier Medical College), Linda Wolff(National Institutes of Health), Yusuke Sotomaru(Hiroshima University), Takeshi Ueda(Kindai University), Zen‐ichiro Honda(Ochanomizu University), Yuichiro Nakata(University of Miami), Shuhei Koide(The University of Tokyo), Hideaki Oda(Hakodate Central General Hospital), Hiroshi Kobayashi(Jikei University School of Medicine)
Cited by 47
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694